This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Cardiac Biomarker Diagnostic Test Kits Market

Market Insights on Cardiac Biomarker Diagnostic Test Kits covering sales outlook, demand forecast & up-to-date key trends

Cardiac Biomarker Diagnostic Test Kits Market by Product Type (Brain Natriuretic Peptide (BNPs) Test Kits, Creatine Kinase MB (CK-MB) Test Kits, Troponin (I&T) Tests Kits, Myoglobin Test Kits), Indication (Angina Pectoris, Acute Myocardial Infarction, Congestive Heart Failure), End Users & Region for 2022-2028

Cardiac Biomarker Diagnostic Test Kits Market Snapshot

[239 Pages Report] The global Cardiac Biomarker Diagnostic Test Kits Market is slated to top US$ 1.8 Bn by the end of 2022, estimates Future Market Insights (FMI). With growing prevalence of cardiac diseases, the overall market is projected to expand at 5.1% CAGR over the forecast period, from 2022 to 2028.

As per the study, sales of brain natriuretic peptide (BNPs) test kits is expected to contribute over half of demand in Cardiac Biomarker Diagnostic Test Kits Market. Demand for BNP test kits is expected to increase on the back of rising incidence of heart failure, coupled with increasing need for cardiac biomarkers to curb the growing burden of cardiovascular ailments.

Attribute

Details

Cardiac Biomarker Diagnostic Test Kits Market Size Value in 2021

US$ 1.8 Billion

Cardiac Biomarker Diagnostic Test Kits Market Size Value in 2028

US$ 2.5 Billion

North America Cardiac Biomarker Diagnostic Test Kits Market Value in 2021

US$ 522.5 Million

CAGR (2021-2028)

~5.1%

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

5.10%

H1, 2022 Projected

5.06%

H1, 2022 Outlook

4.66%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 40 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 44 ↓

According to Future Market Insights analysis, the global cardiac biomarker diagnostic test kits market is expected to drop by 44 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 40 BPS.

Cardiovascular (CV) illness has been diagnosed using a number of cardiac markers. However, there is still a need to search for more modern, more precise molecules due to a lack of sensitivity and specificity to cardiac muscle necrosis. Thus, the dip in the BPS value is associated with - the chances of a false diagnosis and lack of cardiac specificity.

Moreover, cardiac biomarkers pose limitations which also include the high volumes of screen failure due to biomarkers. Additionally, because not every clinical trial site tests every biomarker, the availability of biomarker assays can vary. Additionally, there may be intra- and inter-lab variability due to the use of various tests at various locations.

The methods for evaluating biomarkers may also vary across regional labs and local laboratories in use by different sites. There also exists the need to establish alternative biological sources of the biomarker in use.

All these limitations will be expected to present the above mentioned dip in the BPS values for the cardiac biomarker diagnostic test kits market.

As per the study, sales of brain natriuretic peptide (BNPs) test kits is expected to contribute over half of demand in Cardiac Biomarker Diagnostic Test Kits Market. Demand for BNP test kits is expected to increase on the back of rising incidence of heart failure, coupled with increasing need for cardiac biomarkers to curb the growing burden of cardiovascular ailments.

2022-2028 Cardiac biomarker diagnostic test kits Market Outlook in Comparison to 2013-2021 Growth

The global cardiac biomarker diagnostic test kits market is estimated to be valued at US$ 1.8 Bn in 2022, opines Future Market Insights. The overall demand for cardiac biomarker diagnostic test kits solutions is slated to rise at 5.1% CAGR between 2022 and 2028.

Increasing prevalence of cardiovascular diseases across the globe is the primary factor propelling the growth in the cardiac biomarker diagnostic test kits market. Growing rate of coronary heart disease, congestive heart failure, and angina pectoris is expected to fuel the demand for brain natriuretic peptide (BNP) test kits.

Cardiac Biomarker Diagnostic Test Kits Market Download Report Brochure

As per the study, sales of BNP test kits are expected to increase at 6.8% CAGR over the forecast period. Demand for BNP test kits are expected to increase at an exceptional rate on the back of rising incidence of congestive heart failure across the U.S., India, and China.

Hence, to curb the growing burden of such cardiovascular diseases, sales of cardiac biomarker diagnostic test kits are expected to reach more than US$ 2.5 Bn by the end of 2028.

How is Expansion of Healthcare Industry Affecting Cardiac Biomarker Diagnostic Test Kit Sales?

Following the outbreak of COVID-19, government across the globe are undertaking several initiatives to improve the healthcare infrastructure. Increasing healthcare expenditure, especially across emerging economies such as India, South Korea, and Japan have also increased the demand for advanced medical devices such as cardiac biomarkers diagnostic test kits.

For instance, as per India Brand Equity Foundation (IBEF), the Government of India approved continuation of ‘National Health Mission’ with a budget of US$ 5.10 billion under the Union Budget of 2021-22.

As per this policy, the government will supply advanced medical devices in rural areas for cardiology, neurology, and other diseases to reduce the global mortality burden. A slew of such initiatives across the globe is expected to create growth opportunities for the market.

Further, with such favorable government initiatives, health professionals and private organizations are introducing and establishing diagnostic laboratories, collaborating with leading players such as Abbot Laboratories and others to cater to the growing demand.

This is expected to increase the sales of cardiac biomarker diagnostics test kits across the globe.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Cardiac Biomarker Diagnostic Test Kits Market - Country-wise Analysis

Will India Cardiac Biomarker Diagnostic Test Kits Market Emerge Lucrative in South Asia?

As per the study, sales of cardiac biomarker diagnostic test kits in India are projected to expand at a significant rate over the forecast period. Growth in the region is driven by rising prevalence of obesity in the country resulting in several cardiovascular diseases.

According to the World Health Organization, around 4.77 million people in India suffered from cardiovascular diseases and around 3.1% population suffered from angina pectoris due to obesity.

To curb the burden of growing disease, Government of India is undertaking various initiatives to increase the awareness in rural areas.

For instance, in June 2021, the government introduced funds and self-service healthcare ATMs in rural areas that provides medical testing for cardiology, neurology, and others.

Against this backdrop, several government and private healthcare institutes and diagnostic laboratories are adopting cardiac biomarkers diagnostic test kits to cater to the growing patient pool.

Why is the Demand for Cardiac Biomarker Diagnostic Test Kits Surging in the U.S.?

Chest pain is a common emergency department in the U.S. accounting for 8-10 million visits every year, as per the statistics of the Center for Disease Control and Prevention. Growing incidence of cardiovascular diseases and rising rate of obesity in the country is the primary factor driving the demand in the market.

According to World Health Organization, increasing population with obesity have a higher risk of developing cardiovascular diseases, which is creating growth opportunities for cardiac biomarker diagnostic test kits market in the U.S.

As per Future Market Insights, in terms of value, the U.S. market is expected to account for over 1/3rd of global market by the end of 2028.

How will Brazil Cardiac Biomarker Diagnostic Test Kits Market Fare?

FMI estimates, the market in Latin America is expected to witness sluggish growth through 2021 on the back of low awareness regarding the benefits of cardiac biomarker diagnostic test kits market.

However, with increasing prevalence of cardiovascular diseases in Brazil, demand for these diagnostic test kits are expected to burgeon over the years. As per WHO, mortality rate due to heart failure is increasing, accounting for over 15.60% of total deaths in the country.

In order to reduce the growing rate, government and healthcare organizations are undertaking preventive measures to educate the people regarding the benefits of these test kits. Hence, based on the aforementioned factors, demand for cardiac biomarker diagnostic test kits market in Brazil is expected to surge through 2028.

Cardiac Biomarker Diagnostic Test Kits Market - Category-wise Insights

Why are Brain Natriuretic Peptide (BNPs) Cardiac Biomarker Diagnostic Test Kits Highly Sought-After?

On the basis of product type, the BNP test kit segment is expected to hold lion’s share. As per the study, the segment is expected to account for over 50% of the global market share, with sales estimated to total US$ 682.9 Mn in 2022.

BNP test kits are mostly preferred for the detection of heart failure. With rising incidence of heart failure across the globe among baby boomers and millennials, demand for BNP test kits is expected to increase over the coming years.

On account of this, FMI estimates, sales of BNP test kits in cardiac biomarker diagnostic test kits market are projected to increase at nearly 6.8% CAGR over the forthcoming decade.

Will Rising Incidence of Angina Pectoris Propel the Sales in the Market?

Based on incidence, the angina pectoris segment is expected to be the most lucrative segment in terms of market share. Sales of cardiac biomarker diagnostic test kit due to angina pectoris will surge at over 3.6% CAGR by the end of 2028, estimates FMI.

Increasing prevalence of coronary heart disease have surged the cases of angina pectoris/chest pain, especially among geriatric population. As per World Health Organization, nearly 17 million succumbed to cardiovascular diseases in 2019. Out of which, around 20% were diagnosed with angina pectoris.

Also, with increasing consumption of unhealthy food products, cases of angina pectoris have burgeoned among millennials. Hence, in order to cater to the growing patient pool, demand for cardiac biomarker diagnostic test kits is expected to increase.

Why is Demand for Cardiac Biomarker Diagnostic Test Kits Surging in Diagnostic Laboratories?

As per Future Market Insights, in terms of end users, the diagnostic laboratories segment is expected to dominate the market. With growing prevalence of cardiovascular diseases, patient pool in diagnostic centers has surged over the years for the diagnosis of cardiovascular diseases.

Hence, demand for cardio biomarker diagnostic test kits is expected to increase within diagnostic laboratories. As per the study, revenue from the diagnostic laboratories segment is expected to reach US$ 997.4 Mn, with the segment exhibiting growth at 5.9% CAGR by the end of 2028.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Cardiac Biomarker Diagnostic Test Kits Market - Competitive Landscape

As per FMI, the global cardiac biomarker diagnostic test kit market is expected to be fragmented in nature. Top 6 players are expected to dominate the market, accounting for nearly 75% of total market share.

Leading players are focusing on strategic collaborations with universities and manufacturers to gain competitive edge. Some of the players are also introducing new products and investing heavily in research and development to develop advanced cardiac biomarkers to cater to growing demand.

For instance,

  • In April 2021, Roche announced the launch of a series of five new intended uses for two key cardiac biomarkers using the Elecsys® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These biomarkers assist in supporting cardiovascular disease management and can help clinicians diagnose heart attacks to manage heart failure.
  • In October 2021, Baxter International Inc., a global leader in acute care, joined hands with bioMérieux, a global leader in in vitro diagnostics, to launch the CE marking of the NEPHROCLEAR™ CCL14 Test.

Cardiac Biomarker Diagnostic Test Kits Market - Scope of Report

Attribute

Details

Cardiac Biomarker Diagnostic Test Kits Market  Forecast Period

2021-2028

Cardiac Biomarker Diagnostic Test Kits Market  Historical Data Available for

2016-2020

Cardiac Biomarker Diagnostic Test Kits Market Analysis

US$ Bn for Value

Key Regions Covered

North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and MEA

Cardiac Biomarker Diagnostic Test Kits Market Key Countries Covered

United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.

Key Market Segments Covered

Product Type, Indication, End User, and Region

Cardiac Biomarker Diagnostic Test Kits Market  Key Companies Profiled

  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • BioMérieux SA
  • Randox Laboratories Ltd.
  • Others

Pricing

Available upon Request

Cardiac Biomarker Diagnostic Test Kits Market by Category

By Product Type:

  • Brain Natriuretic Peptide (BNPs) Test Kits
  • Creatine Kinase MB (CK-MB) Test Kits
  • Troponin (I&T) Tests Kits
  • Myoglobin Test Kits
  • Other test kits.

By Indication:

  • Angina Pectoris
  • Acute Myocardial Infarction
  • Congestive Heart Failure
  • Others.

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Outpatient Clinics
  • Academic & Research Institutes

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Middle East & Africa
  • Japan

Frequently Asked Questions

The global cardiac biomarker diagnostic test kits market is expected to reach a valuation around US$ 1.8 Bn in 2021.

Growing prevalence of cardiac diseases, heart failures, and increasing demand for cardiac biomarkers will fuel the sales in the market.

Top 6 players in the global cardiac biomarker diagnostic test kits market are expected to hold around ~75% of the total market share.

As per Future Market Insights, India, Germany, the U.S., the U.K., and China are the top countries driving the demand for cardiac biomarker diagnostic test kits.

North America cardiac biomarker diagnostics test kit market is expected to account for 33% of global sales.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

    2.3. Exclusion and Inclusion

3. Global Economic Outlook

    3.1. Gross Domestic Product by Region & Country, 2021 - 2028

    3.2. Global Healthcare Market Indicators

4. Market Dynamics

    4.1. Macro-Economic Factors

    4.2. Opportunity Analysis

    4.3. Drivers

        4.3.1. Supply Side Drivers

        4.3.2. Demand Side Drivers

    4.4. Restraints

    4.5. Trends

5. Key Inclusion

    5.1. List of Manufacturer and Supplier

    5.2. Key Regulation

    5.3. Reimbursement Scenario

    5.4. Disease Epidemiology

    5.5. Pricing Analysis

6. North America Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028

    6.1. Introduction

    6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        6.2.1. U.S.

        6.2.2. Canada

    6.3. Market Size (US$ Mn) Forecast By Country, 2021-2028

    6.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021

        6.4.1. Troponin Test Kits

        6.4.2. CK-MB Test Kits

        6.4.3. Myoglobin Test Kits

        6.4.4. BNP Test Kit

        6.4.5. Others

    6.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028

    6.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        6.6.1. Angina Pectoris

        6.6.2. Myocardial Infarction

        6.6.3. Congestive Heart Failure

        6.6.4. Others

    6.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028

    6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        6.8.1. Diagnostic Laboratories

        6.8.2. Outpatient Clinics

        6.8.3. Academic and Research Institutes

        6.8.4. Hospitals

    6.9. Market Size (US$ Mn) Forecast By End User, 2021-2028

    6.10. Market Attractiveness Analysis

        6.10.1. By Country

        6.10.2. By Product Type

        6.10.3. By Indication

        6.10.4. By End User

    6.11. Drivers and Restraints: Impact Analysis

    6.12. Key Market Participants - Intensity Mapping

7. Latin America Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        7.2.1. Brazil

        7.2.2. Mexico

        7.2.3. Argentina

        7.2.4. Rest of Latin America

    7.3. Market Size (US$ Mn) Forecast By Country, 2021-2028

    7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021

        7.4.1. Troponin Test Kits

        7.4.2. CK-MB Test Kits

        7.4.3. Myoglobin Test Kits

        7.4.4. BNP Test Kit

        7.4.5. Others

    7.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028

    7.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        7.6.1. Angina Pectoris

        7.6.2. Myocardial Infarction

        7.6.3. Congestive Heart Failure

        7.6.4. Others

    7.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028

    7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        7.8.1. Diagnostic Laboratories

        7.8.2. Outpatient Clinics

        7.8.3. Academic and Research Institutes

        7.8.4. Hospitals

    7.9. Market Size (US$ Mn) Forecast By End User, 2021-2028

    7.10. Market Attractiveness Analysis

        7.10.1. By Country

        7.10.2. By Product Type

        7.10.3. By Indication

        7.10.4. By End User

    7.11. Drivers and Restraints: Impact Analysis

    7.12. Key Market Participants - Intensity Mapping

8. Western Europe Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        8.2.1. Germany

        8.2.2. U.K.

        8.2.3. France

        8.2.4. Italy

        8.2.5. Spain

        8.2.6. Rest of Western Europe

    8.3. Market Size (US$ Mn) Forecast By Country, 2021-2028

    8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021

        8.4.1. Troponin Test Kits

        8.4.2. CK-MB Test Kits

        8.4.3. Myoglobin Test Kits

        8.4.4. BNP Test Kit

        8.4.5. Others

    8.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028

    8.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        8.6.1. Angina Pectoris

        8.6.2. Myocardial Infarction

        8.6.3. Congestive Heart Failure

        8.6.4. Others

    8.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028

    8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        8.8.1. Diagnostic Laboratories

        8.8.2. Outpatient Clinics

        8.8.3. Academic and Research Institutes

        8.8.4. Hospitals

    8.9. Market Size (US$ Mn) Forecast By End User, 2021-2028

    8.10. Market Attractiveness Analysis

        8.10.1. By Country

        8.10.2. By Product Type

        8.10.3. By Indication

        8.10.4. By End User

    8.11. Drivers and Restraints: Impact Analysis

    8.12. Key Market Participants - Intensity Mapping

9. Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        9.2.1. Russia

        9.2.2. Poland

        9.2.3. Rest of Eastern Europe

    9.3. Market Size (US$ Mn) Forecast By Country, 2021-2028

    9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021

        9.4.1. Troponin Test Kits

        9.4.2. CK-MB Test Kits

        9.4.3. Myoglobin Test Kits

        9.4.4. BNP Test Kit

        9.4.5. Others

    9.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028

    9.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        9.6.1. Angina Pectoris

        9.6.2. Myocardial Infarction

        9.6.3. Congestive Heart Failure

        9.6.4. Others

    9.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028

    9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        9.8.1. Diagnostic Laboratories

        9.8.2. Outpatient Clinics

        9.8.3. Academic and Research Institutes

        9.8.4. Hospitals

    9.9. Market Size (US$ Mn) Forecast By End User, 2021-2028

    9.10. Market Attractiveness Analysis

        9.10.1. By Country

        9.10.2. By Product Type

        9.10.3. By Indication

        9.10.4. By End User

    9.11. Drivers and Restraints: Impact Analysis

    9.12. Key Market Participants - Intensity Mapping

10. Asia Pacific Excluding China & Japan Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        10.2.1. India

        10.2.2. Australia and New Zealand

        10.2.3. ASEAN

        10.2.4. Rest of APECJ

    10.3. Market Size (US$ Mn) Forecast By Country, 2021-2028

    10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021

        10.4.1. Troponin Test Kits

        10.4.2. CK-MB Test Kits

        10.4.3. Myoglobin Test Kits

        10.4.4. BNP Test Kit

        10.4.5. Others

    10.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028

    10.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        10.6.1. Angina Pectoris

        10.6.2. Myocardial Infarction

        10.6.3. Congestive Heart Failure

        10.6.4. Others

    10.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028

    10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        10.8.1. Diagnostic Laboratories

        10.8.2. Outpatient Clinics

        10.8.3. Academic and Research Institutes

        10.8.4. Hospitals

    10.9. Market Size (US$ Mn) Forecast By End User, 2021-2028

    10.10. Market Attractiveness Analysis

        10.10.1. By Country

        10.10.2. By Product Type

        10.10.3. By Indication

        10.10.4. By End User

    10.11. Drivers and Restraints: Impact Analysis

    10.12. Key Market Participants - Intensity Mapping

11. China Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021

        11.2.1. Troponin Test Kits

        11.2.2. CK-MB Test Kits

        11.2.3. Myoglobin Test Kits

        11.2.4. BNP Test Kit

        11.2.5. Others

    11.3. Market Size (US$ Mn) Forecast By Product Type, 2021-2028

    11.4. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        11.4.1. Angina Pectoris

        11.4.2. Myocardial Infarction

        11.4.3. Congestive Heart Failure

        11.4.4. Others

    11.5. Market Size (US$ Mn) Forecast By Indication, 2021-2028

    11.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        11.6.1. Diagnostic Laboratories

        11.6.2. Outpatient Clinics

        11.6.3. Academic and Research Institutes

        11.6.4. Hospitals

    11.7. Market Size (US$ Mn) Forecast By End User, 2021-2028

    11.8. Market Attractiveness Analysis

        11.8.1. By Product Type

        11.8.2. By Indication

        11.8.3. By End User

    11.9. Drivers and Restraints: Impact Analysis

    11.10. Key Market Participants - Intensity Mapping

12. Middle East and Africa Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021

        12.2.1. GCC Countries

        12.2.2. South Africa

        12.2.3. Rest of Middle East and Africa

    12.3. Market Size (US$ Mn) Forecast By Country, 2021-2028

    12.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021

        12.4.1. Troponin Test Kits

        12.4.2. CK-MB Test Kits

        12.4.3. Myoglobin Test Kits

        12.4.4. BNP Test Kit

        12.4.5. Others

    12.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028

    12.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021

        12.6.1. Angina Pectoris

        12.6.2. Myocardial Infarction

        12.6.3. Congestive Heart Failure

        12.6.4. Others

    12.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028

    12.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021

        12.8.1. Diagnostic Laboratories

        12.8.2. Outpatient Clinics

        12.8.3. Academic and Research Institutes

        12.8.4. Hospitals

    12.9. Market Size (US$ Mn) Forecast By End User, 2021-2028

    12.10. Market Attractiveness Analysis

        12.10.1. By Country

        12.10.2. By Product Type

        12.10.3. By Indication

        12.10.4. By End User

    12.11. Drivers and Restraints: Impact Analysis

    12.12. Key Market Participants - Intensity Mapping

13. Forecast Factors: Relevance and Impact

14. Forecast Assumptions

15. Market Structure Analysis

    15.1. Market Structure by Tier

    15.2. Market Share Analysis (2017) for Top Players, By Region

16. Competition Analysis

    16.1. Competition Dashboard

    16.2. Competitors Deep Dive

        16.2.1. Abbott Laboratories

        16.2.2. Hoffmann-La Roche AG

        16.2.3. Bio-Rad Laboratories

        16.2.4. Danaher Corporation

        16.2.5. Seimens Healthineers

        16.2.6. Thermofisher Scientific

        16.2.7. Becton, Dickinson and Company

        16.2.8. bioMérieux

        16.2.9. Randox Laboratories Ltd.

17. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 By Region

    17.1. Introduction / Key Findings

    17.2. Historical Market Size (US$ Mn) Analysis By Region

        17.2.1. North America

        17.2.2. Latin America

        17.2.3. Western Europe

        17.2.4. Eastern Europe

        17.2.5. Asia Pacific Excluding Japan And China

        17.2.6. China

        17.2.7. Japan

        17.2.8. Middle East and Africa

    17.3. Market Size (US$ Mn) Forecast By Region

    17.4. Market Attractiveness Analysis By Region

18. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028, By Product Type

    18.1. Introduction/Key Finding

    18.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2021

        18.2.1. Troponin Test Kits

        18.2.2. CK-MB Test Kits

        18.2.3. Myoglobin Test Kits

        18.2.4. BNP Test Kit

        18.2.5. Others

    18.3. Market Size (US$ Mn) Forecast By Product Type, 2021-2028

    18.4. Market Attractiveness Analysis By Product Type

19. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028, By Indication

    19.1. Introduction/Key Finding

    19.2. Historical Market Size (US$ Mn) Analysis By Indication, 2013-2021

        19.2.1. Angina Pectoris

        19.2.2. Myocardial Infarction

        19.2.3. Congestive Heart Failure

        19.2.4. Others

    19.3. Market Size (US$ Mn) Forecast By Indication, 2021-2028

    19.4. Market Attractiveness Analysis By Indication

20. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028, By End User

    20.1. Introduction/Key Finding

    20.2. Historical Market Size (US$ Mn) Analysis By End User, 2013-2021

        20.2.1. Diagnostic Laboratories

        20.2.2. Outpatient Clinics

        20.2.3. Academic and Research Institutes

        20.2.4. Hospitals

    20.3. Market Size (US$ Mn) Forecast By End User, 2021-2028

    20.4. Market Attractiveness Analysis By End User

21. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028

    21.1. Market Value Analysis (US$ Mn)

    21.2. Absolute $ Opportunity

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Expenditure on Health, (% of GDP), by Country, 2021 – 2028 (1/2)

Table 2: CPT code for Cardiac Biomarker 

Table 3: CPT code for Cardiac Biomarker with reimburse limit amounts

Table 4: Epidemiology of Cardiovascular Diseases in different countries (2021) (1/2)

Table 5: Epidemiology of Cardiovascular Diseases in different countries (2021) (2/2)

Table 6: North America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country

Table 7: North America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type

Table 8: North America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication

Table 9: North America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User

Table 10: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country

Table 11: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type

Table 12: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication

Table 13: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User

Table 14: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country

Table 15: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type

Table 16: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication

Table 17: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User

Table 18: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country

Table 19: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type

Table 20: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication

Table 21: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User

Table 22: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country

Table 23: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type

Table 24: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication

Table 25: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User

Table 26: China Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type

Table 27: China Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication

Table 28: China Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User

Table 29: Japan Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type

Table 30: Japan Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication

Table 31: Japan Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User

Table 32: MEA Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country

Table 33: MEA Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type

Table 34: MEA Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication

Table 35: MEA Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User

Table 36: Global Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis- and Opportunity Assessment 2021–2028, By Region 

Table 37: Global Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis- and Opportunity Assessment 2021–2028, By Product Type 

Table 38: Global Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis- and Opportunity Assessment 2021–2028, By Indication 

Table 39: Global Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis- and Opportunity Assessment 2021–2028, By End User 

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: North America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E)

Figure 02: North America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E)

Figure 03: North America Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E)

Figure 04: North America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E)

Figure 05: North America Cardiac Biomarker Diagnostic Test Kits Market Value Analysis

Figure 06: North America Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 07: U.S. Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 08: U.S. Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 09: Canada Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 10: Canada Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 11: North America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028

Figure 12: North America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028

Figure 13: North America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028

Figure 14: North America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028

Figure 15: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E)

Figure 16: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E)

Figure 17: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E)

Figure 18: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E)

Figure 19: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Analysis

Figure 20: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 21: Brazil Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 22: Brazil Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 23: Mexico Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 24: Mexico Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 25: Argentina Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 26: Argentina Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 27: Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 28: Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 29: Latin America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028

Figure 30: Latin America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028

Figure 31: Latin America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028

Figure 32: Latin America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028

Figure 33: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E)

Figure 34: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E)

Figure 35: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E)

Figure 36: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E)

Figure 37: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Analysis

Figure 38: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 39: U.K. Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 40: U.K. Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 41: Germany Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 42: Germany Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 43: France Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 44: France Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 45: Italy  Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 46: Italy Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 47: Spain Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 48: Spain Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 49: Rest of Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 50: Rest of Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 51: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028

Figure 52: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028

Figure 53: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028

Figure 54: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028

Figure 55: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E)

Figure 56: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E)

Figure 57: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E)

Figure 58: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E)

Figure 59: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Analysis

Figure 60: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 61: Russia Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 62: Russia Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 63: Poland Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 64: Poland Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 65: Rest of Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 66: Rest of Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 67: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028

Figure 68: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028

Figure 69: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028

Figure 70: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028

Figure 71: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E)

Figure 72: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E)

Figure 73: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E)

Figure 74: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E)

Figure 75: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Analysis

Figure 76: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 77: India Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 78: India Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 79: Australia & NZ Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 80: Australia & NZ Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 81: ASEAN Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 82: ASEAN Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 83: Rest of APECJ  Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 84: Rest of APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 85: APECJ Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028

Figure 86: APECJ Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028

Figure 87: APECJ Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028

Figure 88: APECJ Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028

Figure 89: China Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E)

Figure 90: China Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E)

Figure 91: China Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E)

Figure 92: China Cardiac Biomarker Diagnostic Test Kits Market Value Analysis

Figure 93: China Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 94: China Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028

Figure 95: China Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028

Figure 96: China Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028

Figure 97: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E)

Figure 98: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E)

Figure 99: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User  (2021 E)

Figure 100: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Analysis

Figure 101: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 102: Japan Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028

Figure 103: Japan Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028

Figure 104: Japan Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028

Figure 105: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E)

Figure 106: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E)

Figure 107: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E)

Figure 108: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E)

Figure 109: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Analysis

Figure 110: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 111: South Africa Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 112: South Africa Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 113: GCC Countries Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn),

Figure 114: GCC Countries Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 115: Rest of MEA  Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 116: Rest of MEA Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028

Figure 117: MEA Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028

Figure 118: MEA Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028

Figure 119: MEA Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028

Figure 120: MEA Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028

Figure 121: Global Cardiac Biomarker Diagnostic Test Kits Market:  Company Share Analysis (2021)

Figure 122: Global Cardiac Biomarker Diagnostic Test Kits Market Share Analysis (%), By Region, 2018 & 2028

Figure 123: Global Cardiac Biomarker Diagnostic Test Kits Market Y-o-Y Analysis (%), By Region, 2021-2028

Figure 124: Global Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Region, 2021-2028

Figure 125: Global Cardiac Biomarker Diagnostic Test Kits Market Share Analysis (%), By Product Type, 2018 & 2028

Figure 126: Global Cardiac Biomarker Diagnostic Test Kits Market Y-o-Y Analysis (%), By Product Type, 2021-2028

Figure 127: Global Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028

Figure 128: Global Cardiac Biomarker Diagnostic Test Kits Market Share Analysis (%), By Indication, 2018 & 2028

Figure 129: Global Cardiac Biomarker Diagnostic Test Kits Market Y-o-Y Analysis (%), By Indication, 2021-2028

Figure 130: Global Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028

Figure 131: Global Cardiac Biomarker Diagnostic Test Kits Market Share Analysis (%), By End User, 2018 & 2028

Figure 132: Global Cardiac Biomarker Diagnostic Test Kits Market Y-o-Y Analysis (%), By End User, 2021-2028

Figure 133: Global Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028

Figure 134: Global Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021

Figure 135: Global Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn),

Figure 136: Global Cardiac Biomarker Diagnostic Test Kits Market Absolute $ Opportunity, 2018 - 2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Respiratory Pathogen Testing Kits Market

Published : June 2020

Healthcare

At-Home Vaginal pH Test Kit Market

Published : January 2019

Healthcare

Preterm Birth Diagnostic Test Kits Market

Published : December 2021

Healthcare

Fertility and Pregnancy Rapid Test Kits Market

Published : February 2022

Google translate

Cardiac Biomarker Diagnostic Test Kits Market